Cargando…
The promise of the gut metabolite propionate for a novel and personalized lipid-lowering treatment
Autor principal: | Osto, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830524/ https://www.ncbi.nlm.nih.gov/pubmed/34686871 http://dx.doi.org/10.1093/eurheartj/ehab723 |
Ejemplares similares
-
The gut microbial metabolite imidazole propionate inhibits metformin action
por: Sugawara, Kenji, et al.
Publicado: (2021) -
Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis
por: Negatu, Dereje Abate, et al.
Publicado: (2019) -
Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis
por: Sehgal, Ratika, et al.
Publicado: (2021) -
Unmasking New Promises: Expanding the Antigen Landscape For Antibody–Drug Conjugates
por: Oberoi, Honey K., et al.
Publicado: (2021) -
Indole-3-Propionic Acid, a Gut Microbiota Metabolite, Protects Against the Development of Postoperative Delirium
por: Zhou, Xue, et al.
Publicado: (2023)